Skip to content

A Rehabilitation Tool to Determine Patient's Stay in Hospital After Joint Replacement

A Rehabilitation Tool to Determine Patient's Stay in Hospital After Joint Replacement

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03776357
Enrollment
9
Registered
2018-12-14
Start date
2019-08-26
Completion date
2020-03-10
Last updated
2022-06-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Total Joint Replacement Surgery

Brief summary

This is the research study of a rehabilitation tool that informs, guides and empowers clinicians to care for their patients. We hope to learn ways to improve patient outcomes, reduce costs and increase value to the healthcare system

Detailed description

The investigator hope to learn co-relation between the rehab tool and clinical findings and analyse association if any. Rehab tool will optimize care according to the patient's specific needs and provided insights to patients length of stay in the hospital. these data driven insights will be used to observe correlation between machine and clinic data

Interventions

DEVICEVERA clinic

A software system used with the Microsoft Kinect intended to support the physical rehabilitation of adults in the clinic and at home.

Sponsors

Derek Amanatullah
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 99 Years
Healthy volunteers
No

Inclusion criteria

* Patient scheduled for Primary unilateral total joint replacement * Patient age should be more than or equal to 18 years. * Patient must speak English

Exclusion criteria

* Patients undergoing bilateral primary knee replacement surgery * Patients undergoing revision knee replacement surgery * No uncorrectable deformity * No deformity greater than 15 degree * No hip arthritis * No wheelchair dependency * Patients not willing and capable to sign the written informed consent

Design outcomes

Primary

MeasureTime frame
Length of Stay in Hospital Through DischargeUp to 2 days

Secondary

MeasureTime frameDescription
Number of Participants Requiring Gait Aid Use3 months post operative visitThe gait aide use ranges in the order of decreasing performance as Nothing \> Cane \> crutch \> walker.
Knee Society Score (KSS)3 months post operative visitTo assess the effectiveness of the device by calculating knee society score (KSS) after surgery. The scale ranges from 0-100 with grading as Score 80-100 - Excellent Score 70-79 - Good Score 60-69 - Fair Score below 60 - Poor
Knee Range of Motion3 months post operative visitTo assess the effectiveness of the device by calculating range of motion (maximum degrees)

Countries

United States

Participant flow

Participants by arm

ArmCount
Experimental
Participants utilize the VERA platform during pre-operative visit to obtain functional outcome scores.
9
Total9

Withdrawals & dropouts

PeriodReasonFG000
Overall StudyLost to Follow-up3

Baseline characteristics

CharacteristicExperimental
Age, Categorical
<=18 years
0 Participants
Age, Categorical
>=65 years
0 Participants
Age, Categorical
Between 18 and 65 years
9 Participants
Ethnicity (NIH/OMB)
Hispanic or Latino
2 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
7 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants
Gait aide use
Cane
0 Participants
Gait aide use
crutch
0 Participants
Gait aide use
Nothing
9 Participants
Gait aide use
walker
0 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
Race (NIH/OMB)
Asian
1 Participants
Race (NIH/OMB)
Black or African American
3 Participants
Race (NIH/OMB)
More than one race
0 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
1 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants
Race (NIH/OMB)
White
4 Participants
Range of motion ( maximum degrees)
Extension
0.6 degrees
STANDARD_DEVIATION 1.7
Range of motion ( maximum degrees)
Flexion
117.8 degrees
STANDARD_DEVIATION 5.7
Region of Enrollment
United States
9 Participants
Sex: Female, Male
Female
5 Participants
Sex: Female, Male
Male
4 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
0 / 9
other
Total, other adverse events
0 / 9
serious
Total, serious adverse events
0 / 9

Outcome results

Primary

Length of Stay in Hospital Through Discharge

Time frame: Up to 2 days

ArmMeasureValue (MEDIAN)
ExperimentalLength of Stay in Hospital Through Discharge2 days
Secondary

Knee Range of Motion

To assess the effectiveness of the device by calculating range of motion (maximum degrees)

Time frame: 3 months post operative visit

ArmMeasureGroupValue (MEAN)Dispersion
ExperimentalKnee Range of Motionextension1.1 degreesStandard Deviation 2.2
ExperimentalKnee Range of Motionflexion107.8 degreesStandard Deviation 17.5
Secondary

Knee Society Score (KSS)

To assess the effectiveness of the device by calculating knee society score (KSS) after surgery. The scale ranges from 0-100 with grading as Score 80-100 - Excellent Score 70-79 - Good Score 60-69 - Fair Score below 60 - Poor

Time frame: 3 months post operative visit

ArmMeasureGroupValue (COUNT_OF_PARTICIPANTS)
ExperimentalKnee Society Score (KSS)Excellent (80-100)6 Participants
ExperimentalKnee Society Score (KSS)Good (70-79)0 Participants
ExperimentalKnee Society Score (KSS)Fair (60-69)2 Participants
ExperimentalKnee Society Score (KSS)Poor ( below 60)1 Participants
Secondary

Number of Participants Requiring Gait Aid Use

The gait aide use ranges in the order of decreasing performance as Nothing \> Cane \> crutch \> walker.

Time frame: 3 months post operative visit

ArmMeasureGroupValue (COUNT_OF_PARTICIPANTS)
ExperimentalNumber of Participants Requiring Gait Aid UseWalker0 Participants
ExperimentalNumber of Participants Requiring Gait Aid UseNone ( no gait aide)9 Participants
ExperimentalNumber of Participants Requiring Gait Aid UseCane0 Participants
ExperimentalNumber of Participants Requiring Gait Aid UseCrutch0 Participants

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026